BPG is committed to discovery and dissemination of knowledge
Articles in Press
6/27/2020 8:52:07 PM | Browse: 175 | Download: 394
Category |
Medicine, Research & Experimental |
Manuscript Type |
Review |
Article Title |
Mesenchymal stem cell-derived exosomes: Toward cell-free therapeutic strategies in regenerative medicine
|
Manuscript Source |
Invited Manuscript |
All Author List |
Zhan-Jun Ma, Jing-Jing Yang, Yu-Bao Lu, Zhao-Yang Liu and Xue-Xi Wang |
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
Chinese Medicine Administration Research Project of Gansu province |
GZK-2019-46 |
Cuiying Technology Innovation Project of Lanzhou University Second Hospital |
CY2019-MS10 |
|
Corresponding Author |
Xue-Xi Wang, MD, Professor, School of Basic Medical Sciences, Lanzhou University, School of Medicine 205 Tianshui Rd South Lanzhou, Lanzhou 730000, Gansu Province, China. wangxuexi@lzu.edu.cn |
Key Words |
Exosomes; Mesenchymal stem cells; Cell-free therapy; Regenerative medicine; Mesenchymal stem cell-derived exosomes; Extracellular vesicles |
Core Tip |
Mesenchymal stem cell-derived exosomes (MSC-Exos) contain a variety of functional proteins, mRNAs, miRNAs, and signaling lipids. MSC-Exos are more stable than their parent cells and do not have the safety issues of living cells, such as tumorigenesis and occlusion of the microvasculature. MSC-Exos represent an alternative to MSC-based therapies for regenerative medicine. In this review, we summarize the characteristics of MSC-Exos and highlight their functions and therapeutic potential for tissue/organ regeneration and for kidney, liver, cardiovascular, neurological, and musculoskeletal diseases, as well as cutaneous wound healing. |
Citation |
Ma ZJ, Yang JJ, Lu YB, Liu ZY, Wang XY. Mesenchymal stem cell-derived exosomes: Toward cell-free therapeutic strategies in regenerative medicine. World J Stem Cells 2020; 12(8): 814-840 |
|
Received |
|
2020-03-15 09:46 |
|
Peer-Review Started |
|
2020-03-15 09:47 |
|
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-04-07 22:56 |
|
Revised |
|
2020-04-23 10:50 |
|
Second Decision |
|
2020-06-22 09:27 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2020-06-27 20:52 |
|
Articles in Press |
|
2020-06-27 20:52 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2020-07-03 02:24 |
|
Typeset the Manuscript |
|
2020-08-21 15:26 |
ISSN |
1948-0210 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345